3RChem specializes in advanced synthetic intermediates for drug discovery. A major bottleneck in drug discovery today is the lack of commercially available advanced building blocks/intermediates for lead generation, optimization and scale-up. Consequently, many pharmaceutical companies have to devote considerable medicinal chemistry resources to the preparation of intermediates/building blocks before important SAR (Structure-Activity Relationship) studies can begin. 3RChem is founded to address this critical need by offering a wide variety of advanced intermediates/building blocks that are specifically tailored for synthesizing new drug-like compounds.